Erythrovet 20%

Kraj: Egipt

Język: angielski

Źródło: EDA (Egyptian Drug Authority)

Ulotka dla pacjenta Ulotka dla pacjenta (PIL)
25-05-2024

Składnik aktywny:

ERYTHROMYCIN THIOCYANATE 216 mg ( eq. to erythromycin 200mg) /g

Dostępny od:

Pharma Swede - Egypt

Forma farmaceutyczna:

Water Soluble Powder

Wyprodukowano przez:

Pharma Swede - Egypt

Ulotka dla pacjenta

                                ERYTHROVET 20% WSP
COMPOSITION: Each 1 gm. contains:
•
Erythromycin Thiocyanate 216 mg. ( Eq. to Erythromycin base)
INDICATIONS : Erythrovet 20% is indicated for treatment of Chronic
Respiratory Disease (CRD) in
chickens caused by Mycoplasma organisms.
DOSAGE : FOR ORAL ADMINISTRATION VIA DRINKING WATER:
Chickens: 127.5 gm. Erythrovet 20%/ 100 liters of drinking water for 1
– 5 days.
CONTRA-INDICATIONS & WARNINGS:
•
Any medicated drinking water which is not consumed within 24 hours
should be discarded.
•
Do not eat, drink or smoke while preparing the diluted formulation or
while animals are
being treated.
•
Wash hands and exposed skin after use.
•
the water system to which the product is added must be in good working
order and the
header tanks and troughs must be free of dust, algae and other
particulate matter.
WITHDRAWAL PERIOD:
•
Animals must not be slaughtered for human consumption during
treatment.
•
Chickens: meat : 6 days from last treatment.
•
Egg for human consumption must not be taken during treatment.
•
Eggs: 6 days from last treatment.
PACKS: 100, 500 & 1000 gm.
                                
                                Przeczytaj cały dokument
                                
                            

Wyszukaj powiadomienia związane z tym produktem

Zobacz historię dokumentów